But so far, the multi-receptor strategy looks to be a major step forward in pharmacological weight management
This calls for more and larger-sized real-world studies to strengthen the evidence that supports the early use of these combinations to improve cardiovascular outcomes and glycemic control in patients with T2DM
Wegovy contains semaglutide, a GLP-1 receptor agonist that helps regulate appetite and blood sugar
Our treatment strategy targets the core features of rosacea: What We Treat Persistent erythema the constant background redness across cheeks, nose, and chin Telangiectasia visible dilated blood vessels (spider veins) on the face Flushing episodes reducing the frequency and intensity of flare-ups Papules and pustules the acne-like bumps in Type 2 rosacea 1
It also shifts the perspective on treating lean individuals, suggesting that, by carefully titrating the dose of semaglutide, therapeutic benefits may be achieved without substantial concern about additional weight loss